ClinTec International, a privately held clinical stage CRO based in Glasgow, Scotland, has opened four fully registered offices in China, Singapore and Thailand. Over the next three months, the company, which is bulking up its presence in Asia Pacific, will open additional offices in South Korea, Taiwan, Malaysia and Indonesia. ClinTec stresses its coverage of emerging markets, declaring it has operations in a UN-like 80 countries. ClinTec claims special expertise in oncology trials. More details....